RXO, Inc.RXONYSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+11.5%
5Y CAGR+16.4%
Studio
Year-over-Year Change

Expenses from normal business operations (SG&A, R&D, etc.)

3Y CAGR
+11.5%/yr
Annual compound
5Y CAGR
+16.4%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$1.02B+21.8%
2024$839.00M+22.3%
2023$686.00M-6.9%
2022$737.00M+35.7%
2021$543.00M+13.4%
2020$479.00M+17.1%
2019$409.00M-